Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells
収録刊行物
-
- Gynecol. Oncol.
-
Gynecol. Oncol. 38 333-339, 1990